Nuveen’s Stryker SYK Stock Holding History

Nuveen’s Portfolio SYK Stock Details SYK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-23,800	Closed	-$5K	–	3361
2020 Q3	$5K	Buy	+23,800	New	+$4.63M	﹤0.01%	3266

Other funds holding SYK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nuveen's SYK Position: Q2 2026 in Review

Nuveen reduced its Stryker (SYK) stake by 8.1% in Q2 2026, selling an estimated $41.8M and leaving 1,505,533 shares worth $474M. The position accounts for 0.11% of the portfolio, ranked #138.

Nuveen first reported a position in SYK in Q2 2013 and has held it in 51 quarters since. The position peaked at $595M in Q3 2024. 2,267 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

Nuveen held 1,505,533 shares of Stryker worth $474M as of Q2 2026.
Nuveen sold 132,515 Stryker shares in Q2 2026, an estimated $41.8M.
Stryker made up 0.11% of Nuveen's portfolio in Q2 2026, its #138 holding.
Nuveen first reported a position in Stryker in Q2 2013 and has held it in 51 quarters since.
Nuveen's Stryker position peaked at $595M in Q3 2024.
2,267 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.